Business Description
TScan Therapeutics Inc
NAICS : 541714
SIC : 2834
ISIN : US89854M1018
Description
Financial Strength
5/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 2.08 | |||||
Equity-to-Asset | 0.55 | |||||
Debt-to-Equity | 0.61 | |||||
Debt-to-EBITDA | -1.15 | |||||
Piotroski F-Score | 3/9 | |||||
Altman Z-Score | 0.4 | |||||
Beneish M-Score | -2.45 | |||||
WACC vs ROIC |
Growth Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | 92.5 | |||||
3-Year EBITDA Growth Rate | -5.4 | |||||
3-Year EPS without NRI Growth Rate | -7.6 | |||||
3-Year FCF Growth Rate | -48 | |||||
Future 3-5Y Total Revenue Growth Rate | -23.29 |
Momentum Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 56.11 | |||||
9-Day RSI | 51.84 | |||||
14-Day RSI | 51.6 | |||||
6-1 Month Momentum % | 142.86 | |||||
12-1 Month Momentum % | 244.4 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 6.51 | |||||
Quick Ratio | 6.51 | |||||
Cash Ratio | 6.44 | |||||
Days Sales Outstanding | 553.61 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -26 | |||||
Shareholder Yield % | -14.38 |
Profitability Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Operating Margin % | -444 | |||||
Net Margin % | -423.86 | |||||
FCF Margin % | -306.45 | |||||
ROE % | -64.85 | |||||
ROA % | -35.6 | |||||
ROIC % | -99.85 | |||||
ROC (Joel Greenblatt) % | -123.85 | |||||
ROCE % | -38.03 |
GF Value Rank
1/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PS Ratio | 15.77 | |||||
PB Ratio | 2.32 | |||||
Price-to-Tangible-Book | 2.32 | |||||
EV-to-EBIT | -3.34 | |||||
EV-to-Forward-EBIT | -2.67 | |||||
EV-to-EBITDA | -3.57 | |||||
EV-to-Revenue | 13.58 | |||||
EV-to-Forward-Revenue | 13.33 | |||||
EV-to-FCF | -4.43 | |||||
Price-to-Net-Current-Asset-Value | 4.78 | |||||
Price-to-Net-Cash | 4.95 | |||||
Earnings Yield (Greenblatt) % | -29.94 | |||||
FCF Yield % | -16.67 |